Froehlich, T. E. et al. Update on environmental risk factors for attention-deficit/hyperactivity disorder. Curr. Psychiatry Rep. 13, 333–344 (2011).
Palladino, V. S., McNeill, R., Reif, A. & Kittel-Schneider, S. Genetic risk factors and gene-environment interactions in adult and childhood attention-deficit/hyperactivity disorder. Psychiatr. Genet. 29, 63–78 (2019).
Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63 (2019).
Nigg, J. T. et al. Working memory and vigilance as multivariate endophenotypes related to common genetic risk for attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 57, 175–182 (2018).
Teroganova, N., Girshkin, L., Suter, C. M. & Green, M. J. DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review. BMC Genet. 17, 27 (2016).
Tsankova, N., Renthal, W., Kumar, A. & Nestler, E. J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355–367 (2007).
Walton, E. et al. Epigenetic profiling of ADHD symptoms trajectories: a prospective, methylome-wide study. Mol. Psychiatry 22, 250–256 (2017).
Hamza, M. et al. Epigenetics and ADHD: toward an integrative approach of the disorder pathogenesis. J. Atten. Disord. 23, 655–664 (2019).
Aberg, K. A. et al. A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry 70, 573–581 (2013).
Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, 3156 (2013).
Schubeler, D. Function and information content of DNA methylation. Nature 517, 321–326 (2015).
Elliott, H. R. et al. Differences in smoking associated DNA methylation patterns in South Asians and Europeans. Clin. Epigenetics. 6, 1 (2014).
Liu, C. et al. A DNA methylation biomarker of alcohol consumption. Mol. Psychiatry 23, 422–433 (2018).
Papale, L. A., Seltzer, L. J., Madrid, A., Pollak, S. D. & Alisch, R. S. Differentially methylated genes in saliva are linked to childhood stress. Sci. Rep. 8, 10785 (2018).
Houtepen, L. C. et al. Childhood adversity and DNA methylation in two population-based cohorts. Transl. Psychiatry 8, 266 (2018).
Li, Y. et al. Lead exposure during early human development and dna methylation of imprinted gene regulatory elements in adulthood. Environ. Health Perspect. 124, 666–673 (2016).
Ladd-Acosta, C. & Fallin, M. D. The role of epigenetics in genetic and environmental epidemiology. Epigenomics 8, 271–283 (2016).
Islam, S. A. et al. Integration of DNA methylation patterns and genetic variation in human pediatric tissues help inform EWAS design and interpretation. Epigenetics Chromatin. 12, 1 (2019).
Gutierrez-Arcelus, M. et al. Tissue-specific effects of genetic and epigenetic variation on gene regulation and splicing. PLoS Genet. 11, e1004958 (2015).
Lappalainen, T. & Greally, J. M. Associating cellular epigenetic models with human phenotypes. Nat. Rev. Genet. 18, 441–451 (2017).
Rakyan, V. K., Down, T. A., Balding, D. J. & Beck, S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12, 529–541 (2011).
van Mil, N. H. et al. DNA methylation profiles at birth and child ADHD symptoms. J. Psychiatr. Res. 49, 51–59 (2014).
Park, S. et al. Associations between serotonin transporter gene (SLC6A4) methylation and clinical characteristics and cortical thickness in children with ADHD. Psychol. Med. 45, 3009–3017 (2015).
Xu, Y. et al. Multiple epigenetic factors predict the attention deficit/hyperactivity disorder among the Chinese Han children. J. Psychiatr. Res. 64, 40–50 (2015).
Dadds, M. R., Schollar-Root, O., Lenroot, R., Moul, C. & Hawes, D. J. Epigenetic regulation of the DRD4 gene and dimensions of attention-deficit/hyperactivity disorder in children. Eur. Child Adolesc. Psychiatry 25, 1081–1089 (2016).
Heinrich, H. et al. Attention, cognitive control and motivation in ADHD: linking event-related brain potentials and DNA methylation patterns in boys at early school age. Sci. Rep. 7, 3823 (2017).
Rijlaarsdam, J. et al. Prenatal unhealthy diet, insulin-like growth factor 2 gene (IGF2) methylation, and attention deficit hyperactivity disorder symptoms in youth with early-onset conduct problems. J. Child Psychol. Psychiatry 58, 19–27 (2017).
Peter, C. J. et al. DNA Methylation signatures of early childhood malnutrition associated with impairments in attention and cognition. Biol. Psychiatry 80, 765–774 (2016).
Sengupta, S. M., Smith, A. K., Grizenko, N. & Joober, R. Locus-specific DNA methylation changes and phenotypic variability in children with attention-deficit hyperactivity disorder. Psychiatry Res. 256, 298–304 (2017).
Gervin, K., Nordeng, H., Ystrom, E., Reichborn-Kjennerud, T. & Lyle, R. Long-term prenatal exposure to paracetamol is associated with DNA methylation differences in children diagnosed with ADHD. Clin. Epigenetics. 9, 77 (2017).
Wilmot, B. et al. Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2. J. Child Psychol. Psychiatry 57, 152–160 (2016).
Chen, Y. C. et al. Neuroanatomic, epigenetic and genetic differences in monozygotic twins discordant for attention deficit hyperactivity disorder. Mol. Psychiatry 23, 683–690 (2018).
van Dongen J., et al. Epigenome-wide association study of attention-deficit/hyperactivity disorder symptoms in adults. Biol. Psychiatry. 86, 599–607 (2019).
Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547–1548 (2008).
Aryee, M. J. et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics 30, 1363–1369 (2014).
Houseman, E. A. et al. Reference-free deconvolution of DNA methylation data and mediation by cell composition effects. BMC Bioinform. 17, 259 (2016)
McCartney, D. L. et al. Identification of polymorphic and off-target probe binding sites on the Illumina Infinium MethylationEPIC BeadChip. Genomics Data. 9, 22–24 (2016).
Conomos, M. P., Reiner, A. P., Weir, B. S. & Thornton, T. A. Model-free estimation of recent genetic relatedness. Am. J. Hum. Genet. 98, 127–148 (2016).
Mowlem, F., Agnew-Blais, J., Taylor, E. & Asherson, P. Do different factors influence whether girls versus boys meet ADHD diagnostic criteria? Sex differences among children with high ADHD symptoms. Psychiatry Res. 272, 765–773 (2019).
Martin, J. et al. A genetic investigation of sex bias in the prevalence of attention-deficit/hyperactivity disorder. Biol. Psychiatry 83, 1044–1053 (2018).
Pedersen, B. S., Schwartz, D. A., Yang, I. V. & Kechris, K. J. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics 28, 2986–2988 (2012).
Roberts, S. et al. Longitudinal investigation of DNA methylation changes preceding adolescent psychotic experiences. Transl. Psychiatry 9, 69 (2019).
Mallik, S. et al. An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays. Brief Bioinform. 20, 2224–2235 (2018)
Pan, H., Holbrook, J. D., Karnani, N. & Kwoh, C. K. Gene, Environment and Methylation (GEM): a tool suite to efficiently navigate large scale epigenome wide association studies and integrate genotype and interaction between genotype and environment. BMC Bioinforma. 17, 299 (2016).
Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
Dweep, H. & Gretz, N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat. Methods 12, 697 (2015).
Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996–1006 (2002).
Ren, X. & Kuan, P. F. methylGSA: a bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing. Bioinformatics 35, 1958–1959 (2019).
Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
Mansell, G. et al. Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array. BMC Genomics. 20, 366 (2019).
Hannon, E. et al. Elevated polygenic burden for autism is associated with differential DNA methylation at birth. Genome Med. 10, 19 (2018).
Perrier, F. et al. Identifying and correcting epigenetics measurements for systematic sources of variation. Clin. Epigenetics. 10, 38 (2018).
Rivero, O. et al. Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. Eur. Neuropsychopharmacol. 23, 492–507 (2013).
Lesch, K. P. et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J. Neural Transm. (Vienna). 115, 1573–1585 (2008).
Liu, Q. R. et al. Addiction molecular genetics: 639,401 SNP whole genome association identifies many “cell adhesion” genes. Am. J. Med Genet. B Neuropsychiatr. Genet. 141b, 918–925 (2006).
Mooney, M. A. et al. Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach. Am. J. Med Genet. B Neuropsychiatr. Genet. 171, 815–826 (2016).
Askland, K., Read, C., O’Connell, C. & Moore, J. H. Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing. Hum. Genet. 131, 373–391 (2012).
Vacic, V. et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471, 499–503 (2011).
Levinson, D. F. et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am. J. Psychiatry 168, 302–316 (2011).
Soria, V. et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 35, 1279–1289 (2010).
Pochini, L., Scalise, M., Galluccio, M. & Indiveri, C. Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health. Front. Chem. 2, 61 (2014).
Simmons-Willis, T. A., Koh, A. S., Clarkson, T. W. & Ballatori, N. Transport of a neurotoxicant by molecular mimicry: the methylmercury–l-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem J. 367, 239–246 (2002).
Stamova, B. et al. Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox. Res. 19, 31–48 (2011).
Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.-M. & Mandelkow, E. MARK, a Novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89, 297–308 (1997).
Ducharme, N. A. et al. MARK2/EMK1/Par-1Bα phosphorylation of Rab11-Family interacting protein 2 is necessary for the timely establishment of polarity in Madin-Darby canine kidney cells. Mol. Biol. Cell. 17, 3625–3637 (2006).
Biernat, J. et al. Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol. Biol. Cell. 13, 4013–4028 (2002).
Drange, O. K. et al. Genetic overlap between alzheimer’s disease and bipolar disorder implicates the MARK2 and VAC14 Genes. Front Neurosci. 13, 220 (2019).
Mick, E., McGough, J. J., Middleton, F. A., Neale, B. & Faraone, S. V. Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 466–472 (2011).
Lee, J. J. et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet. 50, 1112–1121 (2018).
Fleming, M. et al. Educational and health outcomes of children treated for attention-deficit/hyperactivity disorder. JAMA Pediatr. 171, e170691 (2017).
Shadrin, A. A. et al. Novel loci associated with attention-deficit/hyperactivity disorder are revealed by leveraging polygenic overlap with educational attainment. J. Am. Acad. Child Adolesc. Psychiatry 57, 86–95 (2018).
Kim, J. H. et al. De novo mutations in SON disrupt RNA splicing of genes essential for brain development and metabolism, causing an intellectual-disability syndrome. Am. J. Hum. Genet. 99, 711–719 (2016).
Murphy, T. M. et al. Methylomic profiling of cortex samples from completed suicide cases implicates a role for PSORS1C3 in major depression and suicide. Transl. Psychiatry 7, e989 (2017).